# Atea Pharmaceuticals, Inc.: Form SCHEDULE 13D, filed Mar 4, 2025

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: SCHEDULE 13D
- Filed: 2025-03-04
- Accepted by EDGAR: Mar 4, 2025, 09:27 ET
- Period: not reported
- Accession: 0000921895-25-000684
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000092189525000684/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000092189525000684/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000092189525000684/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-000684. Last ingested by Listed: Nov 10, 2026, 04:06 ET. No prices; not investment advice.